Novartis, Voyager Therapeutics reach license option agreement for next-generation gene therapy vectors for neurological diseases Read more
Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site Read more
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus Read more
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency Read more
Pfizer Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics Read more
Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies Read more
Amgen and Generate Biomedicines Announce Multi-Target, Multi-Modality Research Collaboration Agreement Read more